GlaxoSmithKline Q3 profit increases

Posted on: Thu, 05 Nov 2009 10:04:00 EST


Symbols: GSK
Nov 05, 2009 (Datamonitor via COMTEX) --
GSK | Quote | Chart | News | PowerRating -- GlaxoSmithKline has reported a net profit of GBP1.37 billion, or 26.1 pence per diluted share, for the third quarter ended September 30, 2009, compared to GBP1.06 billion, or 20 pence per diluted share, for the third quarter ended September 30, 2008.

For the third quarter of 2009, operating profit was GBP2.07 billion compared to GBP1.66 billion for the third quarter of 2008.

GSK has reported a turnover of GBP6.76 billion for the third quarter of 2009 compared to GBP5.88 billion for the same period of 2008.

For the first nine months ended September 30, 2009, the company has reported a profit of GBP4 billion, or 76.4 pence per diluted share, compared to GBP3.69 billion, or 68.7 pence per diluted share, for the first nine months ended September 30, 2008.

Operating profit for the first nine-month period of 2009 was GBP5.98 billion compared to GBP5.56 billion for the same period of 2008.

For the first nine months of 2009, the turnover was GBP20.27 billion compared to GBP17.44 billion for the same period of 2008.

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon

For full details on GlaxoSmithKline (GSK) GSK. GlaxoSmithKline (GSK) has Short Term PowerRatings at TradingMarkets. Details on GlaxoSmithKline (GSK) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.